TSP48992-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to basimglurant


TSA209919-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant


TSA209958-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant


TSA210009-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant


TSA210063-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant


TSA210119-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant


TSA210173-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant


TSA210225-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant


TSA210280-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant


TSA210327-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant


TSA210363-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant


TSA210415-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant


TSA210454-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant


TSA210507-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant


TSF480302-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 3.33 µM for 24.0 h


1 subfactor(s)
TSF480301-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 10.0 µM for 24.0 h


1 subfactor(s)
TSF480303-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 1.11 µM for 24.0 h


1 subfactor(s)
TSF480304-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.37 µM for 24.0 h


1 subfactor(s)
TSF480305-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.125 µM for 24.0 h


1 subfactor(s)
TSF480306-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.04 µM for 24.0 h


1 subfactor(s)
TSF585493-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 2.22 µM for 24.0 h


1 subfactor(s)
TSF585494-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.74 µM for 24.0 h


1 subfactor(s)
TSF585497-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.03 µM for 24.0 h


1 subfactor(s)
TSF585495-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.25 µM for 24.0 h


1 subfactor(s)
TSF585496-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.08 µM for 24.0 h


1 subfactor(s)
TSF585498-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.01 µM for 24.0 h


1 subfactor(s)
TSF480594-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.37 µM for 24.0 h


1 subfactor(s)
TSF480591-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 10.0 µM for 24.0 h


1 subfactor(s)
TSF480592-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 3.33 µM for 24.0 h


1 subfactor(s)
TSF480593-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 1.11 µM for 24.0 h


1 subfactor(s)
TSF480595-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.125 µM for 24.0 h


1 subfactor(s)
TSF480596-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.04 µM for 24.0 h


1 subfactor(s)
TSF585829-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 2.22 µM for 24.0 h


1 subfactor(s)
TSF585830-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.74 µM for 24.0 h


1 subfactor(s)
TSF585831-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.25 µM for 24.0 h


1 subfactor(s)
TSF585832-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.08 µM for 24.0 h


1 subfactor(s)
TSF585833-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.03 µM for 24.0 h


1 subfactor(s)
TSF585834-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.01 µM for 24.0 h


1 subfactor(s)
TSF480911-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 3.33 µM for 24.0 h


1 subfactor(s)
TSF480910-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 10.0 µM for 24.0 h


1 subfactor(s)
TSF480912-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 1.11 µM for 24.0 h


1 subfactor(s)
TSF480913-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.37 µM for 24.0 h


1 subfactor(s)
TSF480914-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.125 µM for 24.0 h


1 subfactor(s)
TSF480915-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.04 µM for 24.0 h


1 subfactor(s)
TSF586165-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 2.22 µM for 24.0 h


1 subfactor(s)
TSF586166-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.74 µM for 24.0 h


1 subfactor(s)
TSF586167-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.25 µM for 24.0 h


1 subfactor(s)
TSF586168-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.08 µM for 24.0 h


1 subfactor(s)
TSF586169-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.03 µM for 24.0 h


1 subfactor(s)
TSF586170-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.01 µM for 24.0 h


1 subfactor(s)
TSF481241-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 1.11 µM for 24.0 h


1 subfactor(s)
TSF481239-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 10.0 µM for 24.0 h


1 subfactor(s)
TSF481240-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 3.33 µM for 24.0 h


1 subfactor(s)
TSF481242-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.37 µM for 24.0 h


1 subfactor(s)
TSF481243-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.125 µM for 24.0 h


1 subfactor(s)
TSF481244-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.04 µM for 24.0 h


1 subfactor(s)
TSF586503-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.25 µM for 24.0 h


1 subfactor(s)
TSF586504-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.08 µM for 24.0 h


1 subfactor(s)
TSF586501-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 2.22 µM for 24.0 h


1 subfactor(s)
TSF586502-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.74 µM for 24.0 h


1 subfactor(s)
TSF586505-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.03 µM for 24.0 h


1 subfactor(s)
TSF586506-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.01 µM for 24.0 h


1 subfactor(s)
TSF481576-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 3.33 µM for 24.0 h


1 subfactor(s)
TSF481575-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 10.0 µM for 24.0 h


1 subfactor(s)
TSF481577-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 1.11 µM for 24.0 h


1 subfactor(s)
TSF481578-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.37 µM for 24.0 h


1 subfactor(s)
TSF481579-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.125 µM for 24.0 h


1 subfactor(s)
TSF481580-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.04 µM for 24.0 h


1 subfactor(s)
TSF586842-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.01 µM for 24.0 h


1 subfactor(s)
TSF586837-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 2.22 µM for 24.0 h


1 subfactor(s)
TSF586838-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.74 µM for 24.0 h


1 subfactor(s)
TSF586839-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.25 µM for 24.0 h


1 subfactor(s)
TSF586840-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.08 µM for 24.0 h


1 subfactor(s)
TSF586841-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.03 µM for 24.0 h


1 subfactor(s)
TSF481905-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.04 µM for 24.0 h


1 subfactor(s)
TSF481900-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 10.0 µM for 24.0 h


1 subfactor(s)
TSF481901-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 3.33 µM for 24.0 h


1 subfactor(s)
TSF481903-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.37 µM for 24.0 h


1 subfactor(s)
TSF481902-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 1.11 µM for 24.0 h


1 subfactor(s)
TSF481904-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.125 µM for 24.0 h


1 subfactor(s)
TSF587174-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.74 µM for 24.0 h


1 subfactor(s)
TSF587173-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 2.22 µM for 24.0 h


1 subfactor(s)
TSF587175-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.25 µM for 24.0 h


1 subfactor(s)
TSF587176-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.08 µM for 24.0 h


1 subfactor(s)
TSF587177-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.03 µM for 24.0 h


1 subfactor(s)
TSF587178-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.01 µM for 24.0 h


1 subfactor(s)
TSF482236-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.125 µM for 24.0 h


1 subfactor(s)
TSF482232-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 10.0 µM for 24.0 h


1 subfactor(s)
TSF482233-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 3.33 µM for 24.0 h


1 subfactor(s)
TSF482234-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 1.11 µM for 24.0 h


1 subfactor(s)
TSF482235-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.37 µM for 24.0 h


1 subfactor(s)
TSF482237-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.04 µM for 24.0 h


1 subfactor(s)
TSF587512-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.08 µM for 24.0 h


1 subfactor(s)
TSF587509-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 2.22 µM for 24.0 h


1 subfactor(s)
TSF587510-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.74 µM for 24.0 h


1 subfactor(s)
TSF587511-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.25 µM for 24.0 h


1 subfactor(s)
TSF587513-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.03 µM for 24.0 h


1 subfactor(s)
TSF587514-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.01 µM for 24.0 h


1 subfactor(s)
TSF482568-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.04 µM for 24.0 h


1 subfactor(s)
TSF482564-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 3.33 µM for 24.0 h


1 subfactor(s)
TSF482563-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 10.0 µM for 24.0 h


1 subfactor(s)
TSF482565-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 1.11 µM for 24.0 h


1 subfactor(s)
TSF482566-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.37 µM for 24.0 h


1 subfactor(s)
TSF482567-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.125 µM for 24.0 h


1 subfactor(s)
TSF587845-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 2.22 µM for 24.0 h


1 subfactor(s)
TSF587846-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.74 µM for 24.0 h


1 subfactor(s)
TSF587847-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.25 µM for 24.0 h


1 subfactor(s)
TSF587848-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.08 µM for 24.0 h


1 subfactor(s)
TSF587849-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.03 µM for 24.0 h


1 subfactor(s)
TSF587850-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.01 µM for 24.0 h


1 subfactor(s)
TSF482881-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 10.0 µM for 24.0 h


1 subfactor(s)
TSF482882-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 3.33 µM for 24.0 h


1 subfactor(s)
TSF482883-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 1.11 µM for 24.0 h


1 subfactor(s)
TSF482884-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.37 µM for 24.0 h


1 subfactor(s)
TSF482885-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.125 µM for 24.0 h


1 subfactor(s)
TSF482886-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.04 µM for 24.0 h


1 subfactor(s)
TSF588179-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 2.22 µM for 24.0 h


1 subfactor(s)
TSF588180-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.74 µM for 24.0 h


1 subfactor(s)
TSF588181-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.25 µM for 24.0 h


1 subfactor(s)
TSF588182-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.08 µM for 24.0 h


1 subfactor(s)
TSF588183-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.03 µM for 24.0 h


1 subfactor(s)
TSF588184-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.01 µM for 24.0 h


1 subfactor(s)
TSF483194-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 10.0 µM for 24.0 h


1 subfactor(s)
TSF483195-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 3.33 µM for 24.0 h


1 subfactor(s)
TSF483196-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 1.11 µM for 24.0 h


1 subfactor(s)
TSF483197-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.37 µM for 24.0 h


1 subfactor(s)
TSF483198-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.125 µM for 24.0 h


1 subfactor(s)
TSF483199-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.04 µM for 24.0 h


1 subfactor(s)
TSF588513-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.25 µM for 24.0 h


1 subfactor(s)
TSF588511-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 2.22 µM for 24.0 h


1 subfactor(s)
TSF588512-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.74 µM for 24.0 h


1 subfactor(s)
TSF588514-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.08 µM for 24.0 h


1 subfactor(s)
TSF588515-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.03 µM for 24.0 h


1 subfactor(s)
TSF588516-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.01 µM for 24.0 h


1 subfactor(s)
TSF483515-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 10.0 µM for 24.0 h


1 subfactor(s)
TSF483516-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 3.33 µM for 24.0 h


1 subfactor(s)
TSF483517-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 1.11 µM for 24.0 h


1 subfactor(s)
TSF483518-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.37 µM for 24.0 h


1 subfactor(s)
TSF483519-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.125 µM for 24.0 h


1 subfactor(s)
TSF483520-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.04 µM for 24.0 h


1 subfactor(s)
TSF588845-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 2.22 µM for 24.0 h


1 subfactor(s)
TSF588846-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.74 µM for 24.0 h


1 subfactor(s)
TSF588847-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.25 µM for 24.0 h


1 subfactor(s)
TSF588848-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.08 µM for 24.0 h


1 subfactor(s)
TSF588849-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.03 µM for 24.0 h


1 subfactor(s)
TSF588850-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.01 µM for 24.0 h


1 subfactor(s)
TSF483815-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 10.0 µM for 24.0 h


1 subfactor(s)
TSF483816-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 3.33 µM for 24.0 h


1 subfactor(s)
TSF483817-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 1.11 µM for 24.0 h


1 subfactor(s)
TSF483818-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.37 µM for 24.0 h


1 subfactor(s)
TSF483819-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.125 µM for 24.0 h


1 subfactor(s)
TSF483820-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.04 µM for 24.0 h


1 subfactor(s)
TSF589174-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 2.22 µM for 24.0 h


1 subfactor(s)
TSF589175-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.74 µM for 24.0 h


1 subfactor(s)
TSF589176-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.25 µM for 24.0 h


1 subfactor(s)
TSF589177-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.08 µM for 24.0 h


1 subfactor(s)
TSF589178-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.03 µM for 24.0 h


1 subfactor(s)
TSF589179-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.01 µM for 24.0 h


1 subfactor(s)
TSF484149-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 1.11 µM for 24.0 h


1 subfactor(s)
TSF484147-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 10.0 µM for 24.0 h


1 subfactor(s)
TSF484148-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 3.33 µM for 24.0 h


1 subfactor(s)
TSF484150-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.37 µM for 24.0 h


1 subfactor(s)
TSF484151-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.125 µM for 24.0 h


1 subfactor(s)
TSF484152-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.04 µM for 24.0 h


1 subfactor(s)
TSF589510-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.74 µM for 24.0 h


1 subfactor(s)
TSF589511-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.25 µM for 24.0 h


1 subfactor(s)
TSF589509-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 2.22 µM for 24.0 h


1 subfactor(s)
TSF589514-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.01 µM for 24.0 h


1 subfactor(s)
TSF589512-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.08 µM for 24.0 h


1 subfactor(s)
TSF589513-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.03 µM for 24.0 h


1 subfactor(s)
TSS480311-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 3.33 µM for 24.0 h


TSS480310-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 10.0 µM for 24.0 h


TSS480312-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 1.11 µM for 24.0 h


TSS480313-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.37 µM for 24.0 h


TSS480314-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.125 µM for 24.0 h


TSS480315-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.04 µM for 24.0 h


TSS585504-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 2.22 µM for 24.0 h


TSS585505-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.74 µM for 24.0 h


TSS585508-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.03 µM for 24.0 h


TSS585506-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.25 µM for 24.0 h


TSS585507-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.08 µM for 24.0 h


TSS585509-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to basimglurant 0.01 µM for 24.0 h


TSS480603-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.37 µM for 24.0 h


TSS480600-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 10.0 µM for 24.0 h


TSS480601-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 3.33 µM for 24.0 h


TSS480602-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 1.11 µM for 24.0 h


TSS480604-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.125 µM for 24.0 h


TSS480605-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.04 µM for 24.0 h


TSS585840-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 2.22 µM for 24.0 h


TSS585841-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.74 µM for 24.0 h


TSS585842-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.25 µM for 24.0 h


TSS585843-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.08 µM for 24.0 h


TSS585844-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.03 µM for 24.0 h


TSS585845-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to basimglurant 0.01 µM for 24.0 h


TSS480920-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 3.33 µM for 24.0 h


TSS480919-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 10.0 µM for 24.0 h


TSS480921-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 1.11 µM for 24.0 h


TSS480922-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.37 µM for 24.0 h


TSS480923-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.125 µM for 24.0 h


TSS480924-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.04 µM for 24.0 h


TSS586176-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 2.22 µM for 24.0 h


TSS586177-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.74 µM for 24.0 h


TSS586178-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.25 µM for 24.0 h


TSS586179-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.08 µM for 24.0 h


TSS586180-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.03 µM for 24.0 h


TSS586181-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to basimglurant 0.01 µM for 24.0 h


TSS481250-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 1.11 µM for 24.0 h


TSS481248-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 10.0 µM for 24.0 h


TSS481249-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 3.33 µM for 24.0 h


TSS481251-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.37 µM for 24.0 h


TSS481252-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.125 µM for 24.0 h


TSS481253-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.04 µM for 24.0 h


TSS586514-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.25 µM for 24.0 h


TSS586515-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.08 µM for 24.0 h


TSS586512-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 2.22 µM for 24.0 h


TSS586513-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.74 µM for 24.0 h


TSS586516-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.03 µM for 24.0 h


TSS586517-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEK293 after exposure to basimglurant 0.01 µM for 24.0 h


TSS481585-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 3.33 µM for 24.0 h


TSS481584-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 10.0 µM for 24.0 h


TSS481586-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 1.11 µM for 24.0 h


TSS481587-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.37 µM for 24.0 h


TSS481588-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.125 µM for 24.0 h


TSS481589-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.04 µM for 24.0 h


TSS586853-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.01 µM for 24.0 h


TSS586848-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 2.22 µM for 24.0 h


TSS586849-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.74 µM for 24.0 h


TSS586850-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.25 µM for 24.0 h


TSS586851-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.08 µM for 24.0 h


TSS586852-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HELA after exposure to basimglurant 0.03 µM for 24.0 h


TSS481914-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.04 µM for 24.0 h


TSS481909-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 10.0 µM for 24.0 h


TSS481910-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 3.33 µM for 24.0 h


TSS481912-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.37 µM for 24.0 h


TSS481911-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 1.11 µM for 24.0 h


TSS481913-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.125 µM for 24.0 h


TSS587185-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.74 µM for 24.0 h


TSS587184-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 2.22 µM for 24.0 h


TSS587186-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.25 µM for 24.0 h


TSS587187-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.08 µM for 24.0 h


TSS587188-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.03 µM for 24.0 h


TSS587189-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to basimglurant 0.01 µM for 24.0 h


TSS482245-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.125 µM for 24.0 h


TSS482241-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 10.0 µM for 24.0 h


TSS482242-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 3.33 µM for 24.0 h


TSS482243-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 1.11 µM for 24.0 h


TSS482244-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.37 µM for 24.0 h


TSS482246-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.04 µM for 24.0 h


TSS587523-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.08 µM for 24.0 h


TSS587520-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 2.22 µM for 24.0 h


TSS587521-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.74 µM for 24.0 h


TSS587522-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.25 µM for 24.0 h


TSS587524-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.03 µM for 24.0 h


TSS587525-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line JURKAT after exposure to basimglurant 0.01 µM for 24.0 h


TSS482577-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.04 µM for 24.0 h


TSS482573-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 3.33 µM for 24.0 h


TSS482572-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 10.0 µM for 24.0 h


TSS482574-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 1.11 µM for 24.0 h


TSS482575-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.37 µM for 24.0 h


TSS482576-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.125 µM for 24.0 h


TSS587856-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 2.22 µM for 24.0 h


TSS587857-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.74 µM for 24.0 h


TSS587858-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.25 µM for 24.0 h


TSS587859-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.08 µM for 24.0 h


TSS587860-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.03 µM for 24.0 h


TSS587861-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF10A after exposure to basimglurant 0.01 µM for 24.0 h


TSS482890-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 10.0 µM for 24.0 h


TSS482891-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 3.33 µM for 24.0 h


TSS482892-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 1.11 µM for 24.0 h


TSS482893-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.37 µM for 24.0 h


TSS482894-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.125 µM for 24.0 h


TSS482895-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.04 µM for 24.0 h


TSS588190-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 2.22 µM for 24.0 h


TSS588191-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.74 µM for 24.0 h


TSS588192-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.25 µM for 24.0 h


TSS588193-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.08 µM for 24.0 h


TSS588194-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.03 µM for 24.0 h


TSS588195-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to basimglurant 0.01 µM for 24.0 h


TSS483203-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 10.0 µM for 24.0 h


TSS483204-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 3.33 µM for 24.0 h


TSS483205-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 1.11 µM for 24.0 h


TSS483206-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.37 µM for 24.0 h


TSS483207-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.125 µM for 24.0 h


TSS483208-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.04 µM for 24.0 h


TSS588524-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.25 µM for 24.0 h


TSS588522-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 2.22 µM for 24.0 h


TSS588523-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.74 µM for 24.0 h


TSS588525-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.08 µM for 24.0 h


TSS588526-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.03 µM for 24.0 h


TSS588527-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MDAMB231 after exposure to basimglurant 0.01 µM for 24.0 h


TSS483524-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 10.0 µM for 24.0 h


TSS483525-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 3.33 µM for 24.0 h


TSS483526-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 1.11 µM for 24.0 h


TSS483527-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.37 µM for 24.0 h


TSS483528-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.125 µM for 24.0 h


TSS483529-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.04 µM for 24.0 h


TSS588856-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 2.22 µM for 24.0 h


TSS588857-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.74 µM for 24.0 h


TSS588858-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.25 µM for 24.0 h


TSS588859-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.08 µM for 24.0 h


TSS588860-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.03 µM for 24.0 h


TSS588861-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to basimglurant 0.01 µM for 24.0 h


TSS483824-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 10.0 µM for 24.0 h


TSS483825-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 3.33 µM for 24.0 h


TSS483826-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 1.11 µM for 24.0 h


TSS483827-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.37 µM for 24.0 h


TSS483828-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.125 µM for 24.0 h


TSS483829-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.04 µM for 24.0 h


TSS589185-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 2.22 µM for 24.0 h


TSS589186-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.74 µM for 24.0 h


TSS589187-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.25 µM for 24.0 h


TSS589188-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.08 µM for 24.0 h


TSS589189-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.03 µM for 24.0 h


TSS589190-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line THP1 after exposure to basimglurant 0.01 µM for 24.0 h


TSS484158-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 1.11 µM for 24.0 h


TSS484156-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 10.0 µM for 24.0 h


TSS484157-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 3.33 µM for 24.0 h


TSS484159-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.37 µM for 24.0 h


TSS484160-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.125 µM for 24.0 h


TSS484161-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.04 µM for 24.0 h


TSS589521-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.74 µM for 24.0 h


TSS589522-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.25 µM for 24.0 h


TSS589520-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 2.22 µM for 24.0 h


TSS589525-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.01 µM for 24.0 h


TSS589523-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.08 µM for 24.0 h


TSS589524-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line YAPC after exposure to basimglurant 0.03 µM for 24.0 h



TSP48992 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to basimglurant Public

https://clue.io/data/CMap2020#LINCS2020

Experimental design

No experimental design provided

Results

No results provided